Patent · US Active

Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)

US10131673B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Abdellah Tahari · Beerse, BE
Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Samuël Dominique Demin · Ekeren, BE
Lili Hu · Mechelen, BE

Key dates

Filing date	Dec 7, 2015
Grant date	Nov 20, 2018
Priority date	—
Expiry date	Dec 7, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns novel substituted tricyclic pyrazolo pyrimidine compounds of formula (I-a) or (I-b) having antiviral activity, in particular, having an inhibitory activity on the replication of the respiratory syncytial virus (RSV). The invention further concerns the preparation of such novel compounds, compositions comprising these compounds, and the compounds for use in the treatment of respiratory syncytial virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.